Literature DB >> 36119186

Sero-epidemiological survey of SARS-Cov2 in urban slums of a capital city: A cross- sectional study.

Santosh K Nirala1, Bijaya N Naik1, Neha Chaudhary1, Alok Ranjan1, Mala Mahto2, Sanjay Pandey1, Chandra Mani Singh1, Prabhat K Singh3.   

Abstract

Introduction: Slums are the most vulnerable settlements for COVID-19 infection due to overcrowding and unsanitary conditions. Thus, this study was undertaken to determine the level of seroprevalence for SARS-CoV-2 infection among slum dwellers. Material and
Methods: A community-based cross-sectional seroepidemiological survey was conducted at several slums of Patna over four weeks, that is, January 20-February 20, 2021. A total of 650 participants were recruited in the study by applying a two-stage random sampling technique.
Results: Seroprevalence for SARS-CoV-2-specific IgG antibody was found to be 31.5% (95% Confidence Interval (CI): 27.9-35.1). The seropositivity prevalence was found to be statistically higher among participants belonging to the age group of 18-30 years (41.1%), male gender (67.9%), high-risk occupation (70%), below poverty line (BPL) economic status (62.1%), and residing in a hut (51.2%) and kutcha house (42.4%). Further, 262 participants reported having COVID-like symptoms in the preceding 1 month of the survey, which was found to be significantly associated with the seropositivity status.
Conclusion: The finding of the study reflects that a moderate seroprevalence level of COVID-19 infection was acquired in the slum settings of Bihar. Unchecked spread in these informal communities will pose a serious threat to the rest of the bigger sections of urban populations. This indirectly calls for early intervention in the form of preference in the roadmap of COVID-19 vaccination. Copyright:
© 2022 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  COVID-19; IgG antibody; herd immunity; pandemic; serosurvey; slum

Year:  2022        PMID: 36119186      PMCID: PMC9480741          DOI: 10.4103/jfmpc.jfmpc_2127_21

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

The COVID-19 (coronavirus disease) crisis has shown that humans are assailable and are not undeceivable.[1] Thus, communities need to be prepared against the threat of unforeseen pandemics. This public health emergency of the century has crossed over 2 million deaths globally.[2] At present, India stands second in position, next to the USA, with a total number of confirmed cases reported being more than 10 million to date.[2] As far as the state of Bihar is concerned, which is one of the most densely populated states, the first severe acute respiratory syndrome 2 (SARS CoV-2) infection was identified in March 2020, followed by more than 2.5 lakh cases confirmed till now.[3] Further, Bihar remained severely affected and the virus diffused across all 38 districts of Bihar, among which the capital city, Patna, has witnessed the highest number of cases.[4] SARS-CoV-2 virus arouses a rapid immune response in the form of IgM and IgG antibodies in individuals with symptomatic and asymptomatic infection.[5] The development of IgG antibodies indicates the likelihood of potential protection against subsequent infection and also contributes toward herd protection. It is estimated that in the case of SARS-CoV-2, herd immunity will be achieved when approximately 60%–80% of the community develops immunity. Attaining herd immunity will leave only a meager susceptible population in the community, thus leading to a decline in the outbreak.[6] In view of this, the seroprevalence survey for SARS-CoV-2 antibodies in a community delivers the rational measurement of the extent of exposure and spread of infection.[5] Moreover, slums are the most vulnerable settlement for COVID-19 infection due to overcrowding and unsanitary conditions.[78] Inadequate medical facilities and illiteracy further paint them more susceptible to infections.[78] Consequently, insight into the actual extent of infection in the slum population is crucial to recognize the trend and dynamics of infection to plan a competent public health response. Thus, this study was undertaken to determine the level of seroprevalence for SARS-CoV-2 infection among slum dwellers. Our study also intended to determine the clinical-social risk factors for SARS-CoV-2 infection. Furthermore, this research also addresses the health-seeking behavior of individuals with flu-like symptoms from such communities in the present situation.

Methodology

Study design and study setting

A community-based cross-sectional seroepidemiological survey was conducted at several slums of Patna over four weeks, that is, January 20–February 20, 2021. Patna is the capital city of the state of Bihar in eastern India. According to census 2011, 4.5% of the population of Patna resides in 110 slum colonies.[9] Individuals aged >18 years were recruited as study participants as they are at higher risk of exposure to COVID-19 infection.

Ethical consideration

The Institutional Ethics Committee of AIIMS Patna approved the research protocol (IEC/2020/636). The study purpose and procedure were explained to the participants. Written informed consent was obtained from the participants who agreed to take part in the study, and the test results were communicated to them by providing a printed test report copy.

Sample size

A serosurvey done in Mumbai reported that 57%[10] of the slum population had developed antibodies. Taking this prevalence into account and a 5% absolute margin of error with a 95% level of significance, the sample size was estimated to be 377. Furthermore, to adjust for the nature of sampling, a design effect of 1.5 was used and the sample size was increased further by considering 10% non-sampling error, yielding an effective sample size of 621. However, it was decided to target 650 participants for the study.[11]

Sampling technique

A multi-stage random sampling technique was applied for selecting households in slum colonies. First, the entire city was divided into five zones, that is, East, West, North, South, and Central. Then, in the first stage of sampling, the two largest slums (population-wise) were selected from each zone. A total of 10 slums were selected to cover the sample of 650 (65 from each slum) [Figure 1]. In the second stage, households were selected in each slum. The first household was randomly selected from any landmark of the slum and a convention of sticking to the left was followed for selecting households till the desired number was achieved. Lastly, convenience sampling was applied to recruit one eligible individual from each household.
Figure 1

Location of selected slums across Patna (zoomed-in view)

Location of selected slums across Patna (zoomed-in view)

Inclusion criteria

Individuals aged 18–60 years who were willing to participate and give written consent for the same.

Exclusion criteria

Any contraindication to venepuncture.

Study procedure

A single team comprising one medico-social service officer, one intern, one junior resident, and one senior resident was formed to conduct the survey. In each selected slum, a local leader was approached and the study purpose was briefed to him and his support was sought for carrying out the survey. The flowchart for the recruitment of participants is shown in Figure 2. Face-to-face interview of consenting individuals was conducted using a well-designed questionnaire to collect the relevant information. Each selected participant was allocated a three-digit unique identification number. After completing the interview, blood sampling was performed under aseptic precautions and 3 mL of venous blood was collected in a yellow top serum tube with a clot activator. The total collected samples of each day were sent to the central laboratory (Biochemistry) of the institute. In the laboratory, serum was separated from the blood samples by centrifugation and tested for Anti-SARS-CoV-2 IgG antibody. However, out of a total of 650 collected samples, five samples were rejected on the ground of “quantity not sufficient” (QNS) and name mismatch. Printed reports were handed over to the participants by revisiting the area after 2–3 days of surveying each slum.
Figure 2

Flowchart depicting the recruitment of participants in the study

Flowchart depicting the recruitment of participants in the study

Laboratory procedure

The qualitative and semi-quantitative estimation of IgG antibodies to SARS-CoV-2 was done using the “ADVIA Centaur SARS-CoV-2 IgG assay,” which is a chemiluminescent immunoassay (CLIA). The reported sensitivity and specificity of the assay are 100% and 99.8%, respectively. The measuring interval of the assay is 0.50–20.00 index. The samples with <1.00 index were considered non-reactive and reported negative for SARS-CoV-2 IgG antibodies, whereas the samples with ≥1.00 index were considered reactive and reported positive for SARS-CoV-2 IgG antibodies.

Study tool

Face-to-face interviews were conducted using a pretested, semi-structured questionnaire that consisted of a series of questions to extract information pertaining to sociodemographic details of the participants (age, gender, occupation, and housing condition), smoking history, contact history, past history of a confirmed diagnosis of COVID-19 or symptoms suggestive of COVID-19 in the preceding 1 month of the survey, health-seeking behavior, and any comorbidity.

Statistical analysis plan

The collected data were entered, cleaned, and coded in MS Excel. For analysis, age was summarized into three categories: 18–30, 31–44, and 45–60 years. Similarly, occupation was also summarized into three categories based on the risk of exposure: high risk (autorickshaw drivers, rickshaw pullers, street vendors, etc.), low risk (shopkeepers, laborers, housemaids, etc.), and no risk (housewife, retired, unemployed, etc.). Frequency and percentages were used to present the categorical data, whereas mean and standard deviation were used to present the continuous data. Pearson’s Chi-square test and independent t test were used to test the association between the categorical and continuous data, respectively. P < 0.05 was considered statistically significant. All the variables having significant univariate analysis (P < 0.05) were selected for inclusion in the multiple logistic regression. STATA version 13 software was used for the analysis of data. In addition, considering the nature of the sampling technique, the cluster analysis command was used in STATA.

Results

Over 800 households were visited across the 10 selected slums. As many as 150 (18.8%) households refused to take part in the study. In total, 650 blood samples were collected, but five samples were rejected due to the quantity not being sufficient. Finally, 645 samples were analyzed [Figure 3]. Seroprevalence for SARS-CoV-2-specific IgG antibody was found to be 31.5% [95% Confidence Interval (CI): 27.9–35.1]. Table 1 displays the seroprevalence of IgG positivity according to the baseline characteristics of the participants. The mean age of participants in the study was 39.5 (11.2) years, with the majority belonging to the 31–44-years age group (36.6%) followed by 45–60 years (38.1%). More than half of the participants were male (55.7%), and approximately two-thirds of the participants (67.1%) were literate. More than half of the slum dwellers (59.7%) were engaged in occupations with a low risk of exposure to COVID-19, and only 18.3% had occupations with a high risk of exposure. The majority of participants were Hindu by religion (94.4%). Moreover, the seropositivity prevalence was found to be statistically higher among participants belonging to the age group of 18–30 years (41.1%), male gender (67.9%), and high-risk occupation (70%). However, no significant difference in serological status was noted for the educational and religious status of participants. There was almost equal representation from both APL (51.9%) and BPL (48.1%) economic levels. More than half of the slum participants (56.4%) lived in a house; among those, 364 participants residing in a house; a maximum (37.1%) lived in a pucca house, followed by a semi pucca house (33%). The majority of participants (67.6%) denied smoking or chewing tobacco. Adding to it, higher antibody positivity was noted among individuals belonging to BPL economic status (62.1%). Furthermore, the participants residing in a hut (51.2%) and kutcha house (42.4%) were reported to have a higher prevalence of seropositivity. However, tobacco chewing/smoking habit and family type were not found to be associated with seropositivity. Regarding comorbidities, surprisingly, diabetes was found to be significantly associated with IgG positive test rate (17%). Relevant past history was inquired from the participants, which are shown in Table 2. On inquiring about the past history, only 1.3% among seropositive and 0.5% among seronegative disclosed having suffered from COVID infection or having contact with confirmed COVID cases in the past. As many as 262 participants reported having COVID-like symptoms in the preceding 1 month of the survey, and it was found to be significantly associated with the seropositivity status. Furthermore, among the different COVID-like symptoms inquired from the participants, influenza-like illness (ILI) symptoms (48.8%), loss of taste (13.8%), and loss of smell (12.9%) were significantly associated with increased prevalence of IgG antibody as compared to the other COVID-like symptoms. As far as health-seeking behavior is concerned, of those 262 participants who had suffered from COVID-like symptoms in the past, only 40.1% took treatment, and among those who seek treatment, approximately half of them went to a government health facility (47.6%), followed by a private health facility (28.6%), and almost one fourth went to a quack/local healer (23.8%) [Figure 3]. On applying logistic regression, age; male gender; BPL economic status; residing in a kutcha house; occupation with a high risk of exposure; and symptoms such as ILI, loss of taste, and loss of smell in the past emerged as significant independent predictors of seropositivity among slum population [Table 3]. Overall, 24.2% variability of IgG seropositivity rate for SARS-CoV-2 among slum populations was explained by the independent variable in the regression model.
Figure 3

Distribution of participants according to the health-seeking behavior (n = 262)

Table 1

Seroprevalence of COVID IgG antibodies by sociodemographic and other characteristics of participants (n=645)

Characteristicsn (%)IgG positive n [% (95% CI)]P (Chi-square test)
Age (years)
 18-30163 (25.3)84 [41.4 (34.7-48.3)]<0.001*
 31-44236 (36.6)72 [35.5 (29.1-2.3)]
 45-60246 (38.1)47 [23.1 (17.8-29.4)
Gender
 Female286 (44.3)65 [32.1 (25.9-38.7)]0.02*
 Male359 (55.7)138 [67.9 (61.2-74.1)]
Education
 Illiterate212 (32.9)69 [34 (27.8-40.8)]0.639
 Literate433 (67.1)134 [66 (59.1-72.2)]
Occupation
 Low risk385 (59.7)142 [70 (63.2-5.8)]<0.001*
 High risk118 (18.3)35 [17.2 (12.6-23.1)]
 No risk142 (22.0)26 [12.8 (8.8-18.1)]
Religion
 Hindu609 (94.4)187 [92.1 (87.4-95.1)]0.08
 Muslim27 (4.2)14 [6.9 (4.1-11.3)]
 Others9 (1.4)2 [1 (0.2-6.4)]
Family type
 Nuclear296 (45.9)86 [42.4 (35.7-49.3)]0.223
 Joint349 (54.1)117 [57.6 (50.7-4.2)]
Economic level
 APL335 (51.9)77 [37.9 (31.4-44.8)]<0.001*
 BPL310 (48.1)126 [62.1 (55.2-68.5)]
Dwelling
 House364 (56.4)99 [48.8 (41.9-55.6)]0.008*
 Hut281 (43.6)104 [51.2 (44.3-8.1)]
House
 Kutcha106 (29.1)42 [42.4 (33.1-52.4)]0.01*
 Semi-pucca123 (33.8)27 [27.3 (19.3-6.9)]
 Pucca135 (37.1)30 [30.3 (22-40.1)]
Smoking/tobacco chewing
 Yes209 (32.4)61 [30 (24.1-36.7)]0.418
Comorbidities
 DM (yes)81 (12.6)17 [8.4 (5.3-13.1)]0.03*
 HTN (yes)97 (15)26 [12.8 (8.8-18.1)]0.283
 Others (yes)66 (10.2)16 [7.9 (4.8-12.5)]0.18

*Significant, CI=confidence interval, APL=Above poverty line, BPL=Below poverty line, DM=Diabetes Mellitus, HTN=Hypertension

Table 2

Relevant past history of participants according to SARS-CoV-2 seropositivity (n=645)

CharacteristicsIgG negativeIgG positive P
Past history of covid infection
 Yes2 (0.5)3 (1.3)0.489
 No196 (44.3)82 (40.3)
 Don’t Know244 (55.2)119 (58.4)
Past history of contact with covid patient
 Yes17 (3.8)8 (3.9)0.461
 No245 (55.4)102 (50.3)
 Don’t Know180 (40.8)93 (45.8)
Past history of COVID-like symptoms (yes)136 (30.8)126 (62.1)<0.01*
 ILI symptoms (yes)122 (27.6)99 (48.8)<0.001*
 Loss of taste (yes)9 (2.1)28 (13.8)<0.01*
 Loss of smell (yes)9 (2.1)26 (12.9)<0.001*
 Others (yes)26 (5.9)14 (6.9)0.62

*Significant, ILI=Influenza-like illness, Others=Headache, myalgia, nausea, vomiting, loose stools, etc.

Table 3

Independent predictors for SARS-CoV-2 seropositivity

CharacteristicsCOR (95% CI) P AOR (95% CI) P
Age (years)
 18-301<0.0011
 31-440.41 (0.27-0.62)0.41 (0.21-.78)0.007*
 45-00.22 (0.14-0.34)0.14 (0.06-0.32)<0.001*
Gender
 Female1<0.0011
 Male2.12 (1.49-3)2.09 (1.11-3.93)0.02*
Economic level
 APL1<0.0011
 BPL2.29 (1.63-3.22)2.93 (1.23-6.99)0.01*
Dwelling
 House10.0081
 Hut1.57 (1.12-2.19)1
House
 Kutcha11
 Semipucca0.39 (0.21-0.71)0.0020.33 (0.16-0.69)0.033*
 Pucca0.43 (0.24-0.77)0.0040.53 (0.27-1.04)0.06
Occupation
 No risk11
 High risk2.6 (1.62-4.18)0.0022.56 (1.22-5.41)0.01*
 Low risk1.88 (1.05-3.36)0.031.64 (0.65-4.13)0.28
ILI
 No11
 Yes3.49 (2.45-4.98)<0.0012.51 (1.4-4.47)0.002*
Loss of taste
 No11
 Yes6.91 (3.28-14.53)<0.0016.06 (1.96-18.68)0.002*
Loss of smell
 No11
 Yes6.34 (2.99-13.43)<0.0016.15 (1.66-22.75)0.006*
Diabetes
 No11
 Yes0.53 (0.3-0.94)0.032.27 (0.80-6.44)0.12
Pseudo R20.242
Hosmer-Lemeshow test0.81

*Significant, COR=crude odds ratio, ILI=Influenza-like illness, AOR=adjusted odds ratio, CI=confidence interval

Seroprevalence of COVID IgG antibodies by sociodemographic and other characteristics of participants (n=645) *Significant, CI=confidence interval, APL=Above poverty line, BPL=Below poverty line, DM=Diabetes Mellitus, HTN=Hypertension Relevant past history of participants according to SARS-CoV-2 seropositivity (n=645) *Significant, ILI=Influenza-like illness, Others=Headache, myalgia, nausea, vomiting, loose stools, etc. Distribution of participants according to the health-seeking behavior (n = 262) Independent predictors for SARS-CoV-2 seropositivity *Significant, COR=crude odds ratio, ILI=Influenza-like illness, AOR=adjusted odds ratio, CI=confidence interval

Discussion

The analysis of seroprevalence of SARS-CoV-2 antibodies from a citywide sample representative of the slum population indicated that despite the state of Bihar reporting a high number of unprecedented clinically diagnosed COVID cases during the first wave of the pandemic, overall, roughly one-third (31.5%) of the slum inhabitant showed evidence of seroconversion, thus reflecting that a substantial magnitude of the population is still susceptible to the risk of COVID infection. This documented prevalence is in striking contrast from the different surveys conducted by Malani et al.[12] at Mumbai and George et al.[13] at Bangalore slums, which reported that 54.1% and 57.9%, respectively, had evident past exposure to COVID-19. Yet, the seroconversion rate across different slums in Patna surpassed the positive test rates reported by the nationwide first[6] (0.73%) and second seroprevalence study[14] (7.1%) conducted during May–June 2020 and August–September 2020. These instances of lower prevalence might be due to variations in the magnitude of COVID-19 disease burden across Indian states. Also, the first and second national-wide household surveys were conducted in an early phase of immunity, thus explaining the lower seropositivity rate. Another prior study conducted by Mahto et al.[15] among health care workers of Patna, India, also documented a notably lower seroprevalence of 13.3%. Thus, the relatively higher antibody positivity rate in slums is expected out of overcrowding and unfeasible social distancing norm there. Further, the poor practice of hand washing and face mask contribute to spreading the infection.[16171819] Moreover, we found higher antibody positivity among the age group of 18–30 years; male sex; and participants who engaged in occupational categories involving persistent public interaction, such as drivers/rickshaw pullers, and street vendors/shopkeepers. As these subgroups are more active and mobile, they exhibit a difference in the risk of exposure. Moreover, studies have suggested that females have a more responsive attitude toward the COVID pandemic, hence justifying the gender gap.[20] In support of our finding, Murhekar et al.[14] and Khan et al.[21] also reported that young males and those with a higher risk of exposure were more likely to be IgG antibody positive. Association of antibody positivity with BPL economic level and dwelling in a hut and kutcha/semi-pucca house was another interesting finding in the current study. The hygiene hypothesis and immune hypothesis extend viable support to this paradoxical finding. This hypothesis advocates that chronic microbial exposure in poor communities as a result of their environment leads to the evolution of immunity training among them.[2223] Consequently, the severity of COVID infection appeared to be limited in such communities, whereas developed countries suffered higher mortality rates as compared to the developing countries during the pandemic. Diabetes mellitus is an acknowledged risk factor for increased severity of coronavirus disease and worse prognosis, even leading to death.[24] Surprisingly, our study found that among the comorbidities, diabetes mellitus was associated with IgG antibody positivity, suggesting recent subclinical COVID infection and highlighting the susceptibility of slum inhabitants suffering from diabetes, thus necessitating prioritizing them for COVID vaccination. A similar association was reported by Sharma et al.[25] in a repeated population-based study conducted in Delhi. Out of all COVID-like symptoms inquired in the interview, loss of taste, loss of smell, and ILI symptoms experienced by people had higher statistical odds for the development of IgG antibodies. Similarly, Murhekar et al.,[14] Khan et al.,[21] and Makaronidis et al.[26] also reported the association of antibody positivity with a past history of ILI symptoms, loss of taste, and loss of smell. Moreover, among all who suffered, only less than half took treatment for their illness. This indirectly implies that low level of literacy and poor awareness among slum dwellers inculcates poor health-seeking behavior and ultimately leads to underutilization of existing health facilities.[27] To add to it, another terrifying finding that came to light from our study was the misdirected health-seeking practices as a substantial proportion approached local quacks or unqualified persons for their symptoms. In consensus with our finding, Das et al.[28] also documented poor health-seeking behavior of the slum population and their reliance on unqualified practitioners. Besides this, Burra and Chandrashekhar have also mentioned in their study that ignorant individuals believe in the wait-and-watch method on the pretext that minor symptoms would go away with time, neglecting the certainty that progression of disease toward severity can be abandoned by taking prompt action.[2829] Although the current study addressed and probed various determinants for IgG antibody positivity against SARS-CoV02 virus, few limitations remained in the study. First, geriatrics were not included in the study as the fragile blood vessels possess challenges in withdrawing blood for blood sample collection. Second, to avoid recall bias, the participants were asked regarding the recent history of COVID-like symptoms in the preceding 1 month of the survey. Thus, the true estimation regarding the total IgG-positive individuals who had apparent COVID-19 symptoms could not be made. Lastly, we did not test the blood samples for IgM antibodies nor the RT-PCR testing was done for the participants. Thus, the possibility of missing out on active cases cannot be ruled out, leading to a slight underestimation of seroprevalence.

Conclusion

The study was conducted across 10 different slums in Patna after the first wave of the pandemic slackened off. The results revealed that a moderate seroprevalence level of COVID-19 infection was acquired in these settings. Among all subpopulations, slum dwellers are most vulnerable to the spread of COVID-19 infection. A one-size-fits-all approach for controlling the spread is not likely to succeed as it overpasses the prevailing huge difference between the living conditions, economic level, and practices of slum settlements and the other general population. Thus, it is crucial to recognize that specific consideration and intervention are imperative for these settlements to curb the pandemic. Otherwise, unchecked spread in these informal communities will pose a serious threat to the rest of the bigger sections of urban populations. Thus, they should receive an early preference in the roadmap of COVID-19 vaccination. Moreover, repeated serosurvey in the same geographic location is recommended to demonstrate the trend of the emerging pandemic.

Financial support and sponsorship

This research was funded by the institute as an Intramural Project.

Conflicts of interest

There are no conflicts of interest.
  22 in total

Review 1.  Using social and behavioural science to support COVID-19 pandemic response.

Authors:  Jay J Van Bavel; Katherine Baicker; Paulo S Boggio; Valerio Capraro; Aleksandra Cichocka; Mina Cikara; Molly J Crockett; Alia J Crum; Karen M Douglas; James N Druckman; John Drury; Oeindrila Dube; Naomi Ellemers; Eli J Finkel; James H Fowler; Michele Gelfand; Shihui Han; S Alexander Haslam; Jolanda Jetten; Shinobu Kitayama; Dean Mobbs; Lucy E Napper; Dominic J Packer; Gordon Pennycook; Ellen Peters; Richard E Petty; David G Rand; Stephen D Reicher; Simone Schnall; Azim Shariff; Linda J Skitka; Sandra Susan Smith; Cass R Sunstein; Nassim Tabri; Joshua A Tucker; Sander van der Linden; Paul van Lange; Kim A Weeden; Michael J A Wohl; Jamil Zaki; Sean R Zion; Robb Willer
Journal:  Nat Hum Behav       Date:  2020-04-30

2.  Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India.

Authors:  Mala Mahto; Ayan Banerjee; Bijit Biswas; Sushil Kumar; Neeraj Agarwal; Prabhat Kumar Singh
Journal:  Am J Blood Res       Date:  2021-02-15

3.  Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?

Authors:  George M Bwire
Journal:  SN Compr Clin Med       Date:  2020-06-04

4.  Health care seeking behaviour among rural women in Telangana: A cross sectional study.

Authors:  P Mani C Reddy; T Rineetha; D Sreeharshika; Kishore Y Jothula
Journal:  J Family Med Prim Care       Date:  2020-09-30

5.  Disparities in spread and control of influenza in slums of Delhi: findings from an agent-based modelling study.

Authors:  Abhijin Adiga; Shuyu Chu; Stephen Eubank; Christopher J Kuhlman; Bryan Lewis; Achla Marathe; Madhav Marathe; Eric K Nordberg; Samarth Swarup; Anil Vullikanti; Mandy L Wilson
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

6.  Spread of COVID-19 in urban neighbourhoods and slums of the developing world.

Authors:  Anand Sahasranaman; Henrik Jeldtoft Jensen
Journal:  J R Soc Interface       Date:  2021-01-20       Impact factor: 4.118

7.  Does the hygiene hypothesis apply to COVID-19 susceptibility?

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  Microbes Infect       Date:  2020-07-09       Impact factor: 2.700

Review 8.  COVID-19 and diabetes mellitus: from pathophysiology to clinical management.

Authors:  Soo Lim; Jae Hyun Bae; Hyuk-Sang Kwon; Michael A Nauck
Journal:  Nat Rev Endocrinol       Date:  2020-11-13       Impact factor: 47.564

9.  Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India.

Authors:  Anup Malani; Daksha Shah; Gagandeep Kang; Gayatri Nair Lobo; Jayanthi Shastri; Manoj Mohanan; Rajesh Jain; Sachee Agrawal; Sandeep Juneja; Sofia Imad; Ullas Kolthur-Seetharam
Journal:  Lancet Glob Health       Date:  2020-11-13       Impact factor: 26.763

10.  Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.

Authors:  Shuchi Anand; Maria Montez-Rath; Jialin Han; Julie Bozeman; Russell Kerschmann; Paul Beyer; Julie Parsonnet; Glenn M Chertow
Journal:  Lancet       Date:  2020-09-25       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.